Dr. Reddy’s Laboratories Limited (NYSE:RDY) Q2 2026 Earnings Call Transcript October 24, 2025
Dr. Reddy’s Laboratories Limited beats earnings expectations. Reported EPS is $0.19, expectations were $0.18.
Operator: Good day, and welcome our quarter 2 fiscal year 2026 [indiscernible] Limited. I’m Aishwarya Sitharam and I’m part of the Dr. Reddy’s Investor Relations team. [Operator Instructions] I now hand over the conference to Richa Periwal.
Richa Periwal: Thanks, Aishwarya. Good morning,...
